Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7393 p337-341
25 March 2006

This section
Reprint   Photocopy

PDF 150K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

337 Pharmacy drug misuse service guidance published Guidance on commissioning pharmaceutical services for drug misusers in England has been published this week by the National Treatment Agency for Substance Misuse (NTA), the Royal Pharmaceutical Society and the Pharmaceutical Services Negotiating Committee ...more

337 Key role available for pharmacists in managing long-term conditions Pharmacists can be key players in practice-based commissioning and managing long-term conditions but need to promote themselves better, David Colin-Thomé, national clinical director for primary care and clinical lead for long-term conditions at the Department of Health, said at the Primary Care Pharmacists Association annual conference this week ...more

337 Vital test of new pharmacy contract funding still to come This year will be a vital test for the strength of the funding arrangements negotiated last year for the new pharmacy contract ...more

338 NICE tuberculosis guideline addresses adherence Patients' adherence to drug therapy is critical to the success of tuberculosis treatment and an essential element of the National Institute of Health and Clinical Excellence guideline released this week, coinciding with World TB Day on 24 March ...more

338 Emphasis on dermatology training needed Training undertaken by pharmacists in dermatology is generally minimal, and proper training in the area needs to be promoted and encouraged, according to a new report from the All Party Parliamentary Group on Skin ...more

338 Further guidance provided for ADHD therapy in children Where drug treatment is considered appropriate for children and adolescents with attention deficit hyperactivity disorder, methylphenidate, atomoxetine and dexamfetamine are recommended, says the National Institute for Health and Clinical Excellence ...more

338 Training required to fulfil public health role Training for pharmacists to undertake public health roles is lacking, according to Jill Jesson, chairman of the Pharmacy Special Interest Group set up by the UK Public Health Association ...more

338 Donepezil helps in severe Alzheimer's Patients with severe Alzheimer's disease (AD) experience improvements in cognition and ability to undertake activities of daily living after six months of donepezil (Aricept) treatment, according to new data ...more

339 Scotland to ban smoking indoors Smoking will be banned in enclosed public places in Scotland from 26 March and pharmacists are already reporting an increased demand for smoking cessation advice ...more

339 PSNC urges caution over Regulations affecting oxygen supply Careful consideration needs to be given to making changes to the Regulations that affect prescribing of oxygen until there is confidence in the new system, the Pharmaceutical Services Negotiating Committee has warned ...more

339 Department tackles burden of administration on NHS Measures to reduce some of the administrative burdens placed on the NHS were set out in a “Draft simplification plan” by the Department of Health this week ...more

339 Small businesses lose out in Budget announcements Marginal relief on corporation tax for small businesses with profits less than £50,000 will be abolished from 1 April, Chancellor of the Exchequer Gordon Brown announced in his Budget speech this week ...more

339 NSF for older people in Wales launched by health minister The National Service Framework for Older People in Wales was launched this week by health minister John Griffiths ...more

339 Scottish prescription charges NHS prescription charges in Scotland are to increase on 1 April, in line with the increases announced last week in England ...more

339 Mawdsleys support package Mawdsleys is to launch a programme of commercial, professional and marketing support for independent pharmacies ...more

340 SSRI failure does not predict response to other drugs Intolerance or failure to respond to a selective serotonin reuptake inhibitor (SSRI) does not predict a lack of efficacy or intolerance to other antidepressants, including other SSRIs, according to two papers ...more

340 HIV in injecting drug users at 10-year high The proportion of injecting drug users infected with HIV has reached its highest level since 1992, figures released by the Health Protection Agency show ...more

340 SIGN publishes updated guidance on dementia The Scottish Intercollegiate Guidelines Network has published an updated version of its guideline on the management of patients with dementia ...more

340 Feasibility of treating prehypertension proved Drug treatment of prehypertension — blood pressure range of 120–130mmHg systolic or 80–89mmHg diastolic — may prevent or postpone development of hypertension, according to a paper ...more

340 Pharmacy team recognised for substance misuse services A community pharmacy team has been awarded first prize in the Northumberland Care Trust Good Practice Awards 2005 for its substance misuse services ...more

341 European Union funds antibiotic resistance network Research into antimicrobial resistance in Europe is to be co-ordinated by a new network funded under the European Union's research framework programme ...more

341 Vaccine production capacity limiting factor in influenza pandemic Capacity within the manufacturing industry will be the limiting factor when it comes to vaccine production in the event of an influenza pandemic, according to David Salisbury, director of immunisation policy at the Department of Health ...more

341 Finasteride plus contraceptive effective in female hair loss Use of finasteride while taking the oral contraceptive pill improved hair loss in two-thirds of premenopausal women with female pattern hair loss (FPHL), according to a study ...more

341 Flu levels fall Use of antiviral drugs for the prevention or treatment of influenza is no longer indicated, David Salisbury, director of immunisation policy, Department of Health, says in a letter to health care professionals ...more

Back to Top


©The Pharmaceutical Journal